Article
Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype.
International immunopharmacology - 1 Jun 2016
Zhu Wei, Jin Zaishun, Yu Jianbo, Liang Jun, Yang Qingdong, Li Fujuan, Shi Xuekui, Zhu Xiaodong, Zhang Xiaoli
Abstract excerpt
Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders of the intestinal tract. Baicalin, originally isolated from the root of the Chinese herb Huangqin (Scutellaria baicalensis Georgi) and its main active ingredient, has a protective effect against inflammatory responses in several diseases. The present study investigated the effects of baicalin on macrophage polarization and its therapeutic role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
